--- title: "HSN Code for Anticancer Drugs: Methotrexate, 5-FU, Ftorafur | HSN 30049042 GST Rate" description: "Find HSN and GST Rates for 30049042 related to Anticancer Drugs: Methotrexate, 5-FU, Ftorafur with BUSY Accounting - The reliable source for HSN and GST details in India." canonical: "https://busy.in/hsn/hsn-30049042/" --- # HSN Code 30049042: Anticancer Drugs: Methotrexate, 5-FU, Ftorafur - [Section 06: Guide to HSN Section 06](https://busy.in/hsn/section-06/) - [Chapter 30: Pharmaceutical Products](https://busy.in/hsn/chapter-30/) - [Sub-chapter 3004: Medicaments for therapeutic uses](https://busy.in/hsn/sub-chapter-3004/) ## GST rates | Description | CGST | SGST | IGST | CESS | | --- | --- | --- | --- | --- | | Other : Anticancer drugs : Methotrexate, 5-fluorouracil(5-FU) and ftorafur | 2.5% | 2.5% | 5% | 0% | | Other : Anticancer drugs : Methotrexate, 5-fluorouracil(5-FU) and ftorafur | 6% | 6% | 12% | 0% | ## Frequently asked questions ### What products are classified under HSN 30049042 ? It includes Anticancer Drugs: Methotrexate, 5-FU, Ftorafur ### Can we claim ITC on inputs used to trade Anticancer Drugs: Methotrexate, 5-FU, Ftorafur? If your outward supply is taxable, eligible ITC is available subject to general restrictions. For exempt/Nil supplies, reverse credit per Rule 42. ### Does packaging or labelling change the GST for Anticancer Drugs: Methotrexate, 5-FU, Ftorafur? For food/agri items, GST can be 5% when not fresh/chilled and sold as pre‑packaged & labelled; otherwise often Nil. For non‑food items, rates depend on the specific sub‑heading. ### How much GST applies to Anticancer Drugs: Methotrexate, 5-FU, Ftorafur? Under HSN 30049042, Anticancer Drugs: Methotrexate, 5-FU, Ftorafur attracts Varies when sold in taxable form. Describe the exact form on the invoice. ### How should mixed supplies be billed when Anticancer Drugs: Methotrexate, 5-FU, Ftorafur is sold with other items? Use separate invoice lines per HSN and apply the correct rate per line (e.g., Varies for Anticancer Drugs: Methotrexate, 5-FU, Ftorafur; Nil for exempt items if applicable). ### Do e‑way bill and e‑invoice apply for Anticancer Drugs: Methotrexate, 5-FU, Ftorafur? e‑Way bill is needed above ₹50,000 consignment value (subject to exemptions). e‑Invoicing is turnover‑based (presently AATO > ₹5 crore) for B2B supplies. ## India's trade performance: HSN Code 30049042 (FY 2024-25) Source: TradeStat EIDB, Ministry of Commerce & Industry. Values in ₹ Crore (FY 2018-19 to FY 2024-25). - Exports: ₹214 Cr (+5.77% YoY) — 0.0058% of India's total exports - Imports: < ₹1 Crore (+86.84% YoY) — 0.0000% of India's total imports - Trade balance: ₹214 Cr (Surplus); surplus rank #1104 of 12657 HSN codes - Share of Sub-Chapter 3004: 0.11% of its exports; import side 0.01% - Rank within Sub-Chapter 3004: #58 of 149 by export value; import-side #47 ### Key metrics - Export CAGR: 4.54% (FY 2018-19 to FY 2024-25, 7 fiscal years) - National export rank: #1770 of 12657 HSN codes by export value (FY 2024-25) - Peak growth year: +38.13% in FY 2019-20 - Contribution to Sub-Ch. 3004: 0.11% of its exports (FY 2024-25) ## India export-import trade statistics: HSN Code 30049042 7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB. | FY | Exports (₹ Cr) | Exp share | Exp YoY | Exp % of Sub-Ch. 3004 | Imports (₹ Cr) | Imp share | Imp YoY | Imp % of Sub-Ch. 3004 | Trade balance | Exp rank | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | FY 2018-19 | 164.14 | 0.0072% | — | 0.18% | Nil | 0.0000% | — | 0.00% | +164.14 | #1506 | | FY 2019-20 | 226.72 | 0.0103% | +38.13% | 0.22% | < ₹1 Crore | 0.0000% | — | 0.00% | +226.68 | #1215 | | FY 2020-21 | 205.67 | 0.0096% | −9.28% | 0.16% | < ₹1 Crore | 0.0000% | +650.00% | 0.00% | +205.37 | #1335 | | FY 2021-22 | 239.68 | 0.0076% | +16.54% | 0.19% | Nil | 0.0000% | −100.00% | 0.00% | +239.68 | #1483 | | FY 2022-23 | 197.90 | 0.0055% | −17.43% | 0.14% | < ₹1 Crore | 0.0000% | — | 0.00% | +197.88 | #1748 | | FY 2023-24 | 202.59 | 0.0056% | +2.37% | 0.12% | < ₹1 Crore | 0.0000% | +1,800.00% | 0.00% | +202.21 | #1774 | | FY 2024-25 | 214.27 | 0.0058% | +5.77% | 0.11% | < ₹1 Crore | 0.0000% | +86.84% | 0.01% | +213.56 | #1770 | - CAGR (7-year): exports 4.54%/yr, imports —/yr (consistently Surplus) ## Key trade insights: HSN Code 30049042 export-import analysis ### Consistent export growth: 4.54% CAGR over 7 years India's exports under HSN Code 30049042 have grown at a compound annual rate of 4.54% over 7 fiscal years, rising from ₹164.14 Crore in FY 2018-19 to ₹214.27 Crore in FY 2024-25. ### HSN Code 30049042 ranked #1770 among all 12657 HSN codes by export value In FY 2024-25, HSN Code 30049042 ranks #1770 out of 12657 HSN codes by total export value. Within Sub-Chapter 3004, it ranks #58 of 149. By trade surplus, it ranks #1104 of 12657. ### FY 2019-20 was the strongest growth year for HSN Code 30049042 exports The strongest single-year export movement for HSN Code 30049042 was recorded in FY 2019-20, when exports surged by 38.13% over the prior year. ### India maintains a trade surplus of ₹213.56 Crore in HSN Code 30049042 goods In FY 2024-25, India's exports of ₹214.27 Cr exceeded imports of ₹0.71 Cr, resulting in a trade surplus of ₹213.56 Crore — ranking #1104 of 12657 by surplus magnitude. ### HSN Code 30049042 contributes 0.11% of Sub-Chapter 3004 exports — ranked #58 Among the 149 HSN codes under Sub-Chapter 3004, HSN Code 30049042 ranks #58 by export value — accounting for 0.11% of the sub-chapter's total exports in FY 2024-25. On the import side, it holds 0.01% share (rank #47). ## Related HSN Codes in Sub-Chapter 3004 Ranked by export value (FY 2024-25). | Rank | HSN Code | Exports (FY 2024-25) | | --- | --- | --- | | #1 | [HSN Code 30049099: Other therapeutic or prophylactic use products](https://busy.in/hsn/hsn-30049099/) | ₹82,761 Cr | | #2 | [HSN Code 30049049: Other \| Anticancer Drugs](https://busy.in/hsn/hsn-30049049/) | ₹19,872 Cr | | #3 | [HSN Code 30049079: Other \| Antihypertensive Drugs](https://busy.in/hsn/hsn-30049079/) | ₹9,153 Cr | | #4 | [HSN Code 30049069: Nonsteroidal Analgesics & Antipyretics: Other Medicaments](https://busy.in/hsn/hsn-30049069/) | ₹7,577 Cr | | #5 | [HSN Code 30049039: Other Antihistaminics/Antacids/Antiulcer/Antiemetics](https://busy.in/hsn/hsn-30049039/) | ₹5,465 Cr | | #6 | [HSN Code 30041090: Other Penicillins or Streptomycins](https://busy.in/hsn/hsn-30041090/) | ₹3,685 Cr | | #7 | [HSN Code 30042019: Other Cephalosporin Antibiotics](https://busy.in/hsn/hsn-30042019/) | ₹3,036 Cr | | #8 | [HSN Code 30049081: Antiepileptic & Sulfa Drugs](https://busy.in/hsn/hsn-30049081/) | ₹2,870 Cr | | #9 | [HSN Code 30049082: Other Antiepileptic Drugs](https://busy.in/hsn/hsn-30049082/) | ₹2,860 Cr | | #10 | [HSN Code 30049029: Other Anthelmintic/Antiamoebic/Antifungal Drugs](https://busy.in/hsn/hsn-30049029/) | ₹2,697 Cr | | #58 | HSN Code 30049042: Anticancer Drugs: Methotrexate, 5-FU, Ftorafur (this hsn code) | ₹214 Cr |